• COMITÉ CIENTÍFICO Y ORGANIZADOR: Dres. Enrique Aman, Claudio Martín, José Menéndez

INVITADOS INTERNACIONALES

Dr. Ignacio Wistuba

EE.UU.

Dr. Ignacio Wistuba

EE.UU.

Dr. Wistuba is the Division Head ad interim in the Division of Pathology and Laboratory Medicine as well as Professor and Chair of the Department of Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center. He serves as the Director of the University of Texas Lung SPORE Tissue Bank, Director of the ECOG-ACRIN Central Biorepository and Pathology Facility (EA CBPF), Co-Director of the pre-CLIA Genomic Testing Developmental Laboratory, and pathologist for the SWOG Lung Cancer Committee. One of his major research interests is the elucidation of the molecular abnormalities involved in the pathogenesis and progression of lung cancer. His research interests also include identifying new molecular targets, validating biomarkers for targeted therapy and immunotherapy, and identifying molecular markers associated with lung cancer tumor development, progression, and metastasis development using annotated human specimens. In addition, he has established an invaluable tissue bank resource for thoracic malignancies at MD Anderson. Dr. Wistuba has co-authored over 700 peer-reviewed papers on oncology and is the principal investigator (PI) or co-PI on several molecular pathology and biomarker projects supported by multi-investigators and multi-institutional grants, and research agreements, including The University of Texas Lung Cancer NCI-SPORE grant, MD Anderson NCI-CCSG Tissue Bank and Pathology Resource, CPRIT Multi-Investigators Research Awards, and NCI-U24 grants to include ECOG-ACRIN CBPF and MD Anderson Center for Immune Monitoring Analysis of Cancer (CIMAC).

Dra. Paula Ugalde

EE.UU.

Dra. Paula Ugalde

EE.UU.

Dr. Paula Ugalde Figueroa established herself as a thoracic surgeon dedicated to research. She has an extensive record of publications including an impressive body of work on thoracic surgery using innovative uniportal VATS approaches for lung cancer. Dr. Ugalde oversaw the creation of the lung cancer database at Laval University, and under her guidance the university became the largest contributor in the world of cases to the prospective database maintained by the International Association for the Study of Lung Cancer (IASLC).
Dr. Ugalde has served on the IASLC Board of Directors since 2021, as well as being a member of the American Association of Thoracic Surgery (AATS), Society of Thoracic Surgeons (STS), and various associated committees. Additionally, Dr. Ugalde is the acting Chair of International Affairs for the Women in Thoracic Surgery society.
She made the move to Boston, Massachusetts in the fall of 2021, where she joined the Division of Thoracic and Cardiac Surgery at Brigham and Women’s Hospital as an Associate Thoracic Surgeon. As part of a major teaching hospital, Dr. Ugalde is also a Member of the Faculty at Harvard Medical School and a staff member of Dana-Farber Cancer Institute.
She has helped introduce minimally invasive thoracic surgery in Brazil and Latin America by training hundreds of thoracic surgeons, including a teaching a Latin American fellow in Québec each year who then returns to his or her home country. Dr. Ugalde continues to embrace the role of being a mentor and role model to young women in thoracic surgery through her work internationally and with a focus on developing countries.

Dr. Luis Seijo Maceiras

España

Dr. Luis Seijo Maceiras

España

Investigador de amplia experiencia en Neumología, cuidados intensivos y endoscopía respiratoria. Formado en las universidades de Columbia (BA en 1990) y Pennsylvania (MD en 1995). Doctorado en medicina por la Universidad de Navarra en 2015. Especialista en el diagnóstico del cáncer de pulmón y en técnicas broncoscópicas avanzadas incluyendo la navegación electromagnética y la ecobroncoscopía. Investigador en terapias endoscópicas del enfisema pulmonar y detección precoz del cáncer de pulmón y coordinador de proyectos relacionados con la intersección del cáncer de pulmón, la enfermedad pulmonar obstructiva crónica y las apneas de sueño (FIS 2020 Proyecto Ecco). Coordinador del plan estratégico de investigación en cáncer de pulmón del CIBER enfermedades respiratorias para el trienio 2016-2018. Investigador en biomarcadores de cáncer de pulmon y EPOC, radiomica en cáncer de pulmon y Covid 19, e investigador de varios ensayos clínicos durante la pandemia. Coordinador de oncología Torácica de la SEPAR y co-coordinador del proyecto Cassandra de cribado de cáncer de pulmón.

Dr. Mariano Provencio

España

Dr. Mariano Provencio

España

Professor Mariano Provencio graduated in Medicine and Surgery in 1986 from the University Alcalá de Madrid,and gained his doctorate cum laude from the same university in 1997. He specialised as a resident physician in Medical Oncology in the Hospital Universitario Puerta de Hierro, in Madrid. His background was completed in 1995 when he was awarded the European Certificate in Medical Oncology in Paris. He later spent time at the Memorial Sloan-Kettering Cancer Center, New York in 2003, at MD Anderson, Houston in 2006 and 2012, and at the Lee Moffit Cancer Center, Tampa, in 2009. After finishing his residency, he joined the Medical Oncology Service in Puerta de Hierro Hospital in Madrid.
In 2011 he was appointed Head of the Medical Oncology Department in Puerta de Hierro University Hospital Majadahonda, Madrid, and became the Director of the Puerta de Hierro Research Institute. He is a Full Professor in the Autonomous University of Madrid.
He is the author of more 300 peer-reviewed papers and several books chapters. His publications have >20,000 citations (h-index of 57, i10-index of 180).
Since 2014, Professor Provencio has been President of the Spanish Lung Cancer Group.

PROGRAMA


05 | MAY
08.30hs.

08:30 - 09:00hs. (UTC-3)

Acreditación
09.00hs.

09:00 - 09:15hs. (UTC-3)

Palabras de bienvenida
Dr. Alejandro Videla

Presidente Asociación Argentina de Medicina Respiratoria


Dr. José Menéndez

Comité Organizador

09.15hs.

09:15 - 09:50hs. (UTC-3)

COVID: PRESENTE Y FUTURO
Disertante: Dr. Alejandro Videla

Coordinadores: Dr. Pablo Fescina, Dr. Aldo Pi

09.50hs.

09:50 - 10:20hs. (UTC-3)

SCREENING
Disertante: Dr. Luis Miguel Seijo Maceiras

Coordinadores: Dra. Iris Boyeras Navarro, Dr. José Luis Morero

10.20hs.

10:20 - 10:50hs. (UTC-3)

AVANCES EN MARCADORES PREDICTIVOS EN TERAPIAS BLANCO E IMMUNOTERAPIA EN CÁNCER DE PULMÓN
Disertante: Dr. Ignacio Wistuba

Coordinadoras: Dra. Laura Legina, Dra. Romina Girotti

10.50hs.

10:50 - 11:20hs. (UTC-3)

Intervalo café
11.20hs.

11:20 - 12:15hs. (UTC-3)

SIMPOSIO: ACTUALIZACIÓN DEL ESTUDIO CROWN EN PRIMERA LÍNEA EN PACIENTES ALK+: ¿TODO SE TRATA DE LA ENFERMEDAD CEREBRAL?
Disertante: Dra. María Virginia Bluthgen

CASOS CLÍNICOS
Disertante: Dr. Guillermo Streich

Presidente: Dr. Nicolás Minatta

12.15hs.

12:15 - 12:45hs. (UTC-3)

DESAFIANDO LAS GUÍAS DE ESTATIFICACIÓN MEDIASTÍNICA INVASIVA
Disertante: Dra. Paula Ugalde

Coordinadores: Dr. Alfredo Aquino, Dr. Gustavo Lyons

12.45hs.

12:45 - 13:15hs. (UTC-3)

TÉCNICAS DIAGNÓSTICAS ENDOSCÓPICAS AVANZADAS DE CÁNCER DE PULMÓN
Disertante: Dr. Luis Miguel Seijo Maceiras

Coordinadores: Dr. Alberto López Araoz, Dr. Juan Manuel Luchelli

13.15hs.

13:15 - 14:15hs. (UTC-3)

SIMPOSIO: REDEFINIENDO LA SOBREVIDA A LARGO PLAZO Y EL POTENCIAL DE LA TERAPIA DUAL EN 1L NSCLC
Disertante: Dr. Mariano Provencio

Coordinador: Dr. Claudio Martín

14.15hs.

14:15 - 14:50hs. (UTC-3)

RADIOTERAPIA CON TÉCNICA SBRT PARA PACIENTES CON CÁNCER DE PULMÓN
Disertante: Dr. Matías Zapata

Coordinadores: Dr. Máximo Barros, Dra. Vanesa Krakobsky

14.50hs.

14:50 - 15:20hs. (UTC-3)

INTERVALO CAFÉ
15.20hs.

15:20 - 16:20hs. (UTC-3)

SIMPOSIO: ESTADÍO TEMPRANO DE CÁNCER DE PULMÓN EN LA ERA MOLECULAR
Disertante: Dr. Andrés Felipe Cardona

Presidente: Dra. Carmen Pupareli

16.20hs.

16:20 - 16:50hs. (UTC-3)

NTRK, Kras, RET
Disertante: Dr. Mariano Provencio

Coordinadores Dra. Carmen Pupareli, Dr. Gonzalo Recondo

16.50hs.

16:50 - 17:20hs. (UTC-3)

LO QUE LOS CIRUJANOS DEBEN SABER SOBRE STAS
Disertante: Dra. Paula Ugalde

Coordinadores: Dr. Horacio Hernestrosa, Dra. Tamara Portas

17.20hs.

17:20 - 17:40hs. (UTC-3)

OPTIMUS PANEL: UTILIZACIÓN PRÁCTICA DE PANELES MULTIGÉNICOS POR NGS CON MOLECULAR TUMOR BOARD PARA NSCLC
Disertante: Dra. Romina Girotti
17.40hs.
Cierre de sesiones
06 | MAY
08.30hs.

08:30 - 09:10hs. (UTC-3)

CONFERENCIA: CSATS: DESBLOQUEANDO EL PODER DE LOS DATOS PARA POTENCIAR LA TÉCNICA MÍNIMAMENTE INVASIVA
Disertante: Dr. Daniel Martínez
09.10hs.

09:10 - 09:45hs. (UTC-3)

VALOR DE LAS VARIACIONES DEL ctDNA EN LA BIOPSIA LÍQUIDA
Disertante: Dr. Mariano Provencio

Coordinadores: Dr. Diego Enrico, Dr. Nicolás Minatta

09.45hs.

09:45 - 10:10hs. (UTC-3)

IMÁGENES EN CÁNCER DE PULMÓN. SITUACION ACTUAL Y PERSPECTIVAS
Disertante: Dra. Lucrecia Cuneo

Coordinadores: Dr. Gustavo Criscuolo, Dr. Lisandro Paganini

10.10hs.

10:10 - 10:40hs. (UTC-3)

INTERVALO CAFÉ
10.40hs.

10:40 - 11:10hs. (UTC-3)

IMPLEMENTACIÓN DE UN PROGRAMA ERAS EN LATINOAMÉRICA
Disertante: Dr. Adrián Álvarez

Coordinadores: Dr. Santiago McLoughlin, Dr. José Menéndez

11.10hs.

11:10 - 11:50hs. (UTC-3)

PRONÓSTICO ONCOLÓGICO A LARGO PLAZO EN PACIENTES T3N0
Disertante: Dra. Paula Ugalde

Coordinadores: Dr. David Smith, Dr. Hernán Pfeiffer

11.50hs.

11:50 - 12:30hs. (UTC-3)

EL USO DE UN BIOMARCADOR EN SANGRE EN LA VALORACIÓN DE NÓDULOS PULMONARES INDETERMINADOS
Disertante: Dr. Luis Miguel Seijo Maceiras

Coordinadoras: Dra. Ada Blinder, Dra. Yanina Powazniak

12.30hs.

12:30 - 13:30hs. (UTC-3)

SIMPOSIO: ROL DEL EQUIPO MULTIDISCIPLINARIO EN EL MANEJO DEL CÁNCER DE PULMÓN - NUEVOS DESAFÍOS
Disertantes: Dra. Iris Boyeras Navarro, Dr. Claudio Martin, Dr. Gustavo Lyons
13.30hs.

13:30 - 14:10hs. (UTC-3)

AVANCES EN LA PATOLOGÍA MOLECULAR DEL CÁNCER DE CÉLULAS NO PEQUEÑAS
Disertante: Dr. Ignacio Wistuba

Coordinadores: Dra. Gabriela Acosta Haab, Dr. Nicolás Castagnaris

14.10hs.

14:10 - 14:40hs. (UTC-3)

ALTERNATIVAS EN ALK
Disertante: Dr. Mariano Provencio

Coordinadores: Dr. Diego Kaen, Dr. Manglio Rizzo

14.40hs.

14:40 - 15:10hs. (UTC-3)

INTERVALO CAFÉ
15.10hs.

15:10 - 16:45hs. (UTC-3)

AVANCES EN NEOADYUVANCIA
Disertante: Dr. Mariano Provencio

Coordinadores: Dr. Diego Kaen, Dr. Manglio Rizzo


RETOS TÉCNICOS DE LA CIRUGÍA PULMONAR TRAS TERAPIA DE INDUCCIÓN CON TKIs O INMUNOTERAPIA
Disertante: Dra. Paula Ugalde

PAPEL DEL PATÓLOGO QUIRÚRGICO Y MOLECULAR EN TERAPIAS NEOAYUDANTES EN CÁNCER PULMONAR
Disertante: Dr. Ignacio Wistuba

Coordinadores: Dra. Virginia Bluthgen, Dr. Juan Cundom, Dr. Agustín Dietrich, Dra. Claudia Poleri


CASO CLÍNICO
Disertante: Dra. Florencia Tsou

Coordinador: Dr. Claudio Martín

16.45
CLAUSURA